XCHG management says H1 2026 revenue falls 17.5% on trade policy turbulence, shifting renewable rules
Bitget2026/09/18 20:07- In management commentary for the six months ended June 30, 2026, revenue fell 17.5% to US$10.3 million on delayed customer procurement decisions.
- Product revenue dropped 21.7% to US$9.5 million; management cited trade policy turbulence and shifting renewable energy rules affecting late-2025 ordering.
- Gross margin narrowed to 38.8% from 51.3% as lower-margin products rose in the mix, while higher silver and copper costs lifted cost of sales.
- Operating expenses rose 9.2% to US$15.2 million, led by higher promotion spending and higher professional fees, partly offset by lower outsourcing R&D.
- Net loss widened to US$11.1 million from US$7.3 million; management pointed to softer revenue and higher cost intensity.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
Crypto prices
More
